EUROFExpansionbusinesswire

Eurofins Viracor BioPharma Announces Relocation to New State-of-the-Art Facility

Sentiment:Positive (70)

Summary

(EUROF) LENEXA, Kan.--(BUSINESS WIRE)--Eurofins Viracor BioPharma Services, a recognized leader in analytical testing and clinical trial services, announces the infrastructure enhancement of its headquarters and laboratory operations to a new, custom-built 96,000 sq. ft. facility in Lenexa, Kansas, scheduled for completion in September 2025. This strategic move, although only a few miles from its previous location, marks a significant milestone in the company’s continued growth and commitment to delive

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 29, 2025 by businesswire

    Eurofins Viracor BioPharma Announces Relocation to New State-of-the-Art Facility | EUROF Stock News | Candlesense